Announcements Trials
Browse Landscape

Phase

Phase 2 3Phase 3 2

Status

Unknown 2Recruiting 1Not yet recruiting 1Completed 1

Sponsor Class

OTHER 23INDUSTRY 5UNKNOWN 1

Study Type

Interventional 5

Sponsor

Cancer Type

Gastrointestinal 4Other neoplasm 1

Conditions

Stomach Neoplasms 2Pancreatic Neoplasms 2Malignant Neoplasms of Digestive Organs 1

Interventions

pembrolizumab 1019Carboplatin 959Paclitaxel 932Gemcitabine 793Cisplatin 748Docetaxel 682Bevacizumab 610Pemetrexed 502Nivolumab 486Cyclophosphamide 466Capecitabine 461Fluorouracil 417Dexamethasone 402Rituximab 372Oxaliplatin 347Injections 342atezolizumab 297Trastuzumab 297Leucovorin 286Cetuximab 282Irinotecan 266130-nm albumin-bound paclitaxel 252Prednisone 244Doxorubicin 240Ipilimumab 226Lenalidomide 220Fulvestrant 217fludarabine 214durvalumab 205Erlotinib Hydrochloride 188

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

5 trials
RecentStart dateEnrollment
INDUSTRY × Interventional × gimeracil × Clear all
NCT07262567 2025-12-03

Phase III Study to Compare GFH375 and Chemotherapy in Patients With KRAS G12D-Mutant Metastatic Pancreatic Cancer

Genfleet Therapeutics (Shanghai) Inc.

Phase 3 Not yet recruiting
320 enrolled
Gastrointestinal

Pancreatic Neoplasms

NCT05934331 2025-09-12

A LM-302 Combination With Other Anti-Tumor Therapies Phase ll Study

LaNova Medicines Limited

Phase 2 Recruiting
276 enrolled
Other neoplasm

Malignant Neoplasms of Digestive Organs

NCT01515748 2023-12-13

PRODIGY

Sanofi

Phase 3 Completed
530 enrolled 11 charts
Gastrointestinal

Stomach Neoplasms

NCT04571489 2020-10-01

A Phase II Study of Gimatecan (ST1481) in Locally Advanced or Metastatic Pancreatic Cancer

Lee's Pharmaceutical Limited

Phase 2 Unknown
60 enrolled
Gastrointestinal

Pancreatic Neoplasms

NCT02504229 2015-07-21

DC-CIK In Combination With Chemotherapy ( Gio / Oxaliplatin or Cisplatin ) Versus First-line Chemotherapy for Locally Advanced Unresectable or Metastatic Gastric Adenocarcinoma Randomized Controlled Phase II Clinical Study of Treatment

Beijing Biohealthcare Biotechnology Co.,Ltd

Phase 2 Unknown
80 enrolled
Gastrointestinal

Stomach Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡